Back Pain And Sciatica Spray
NDC Package 50845-0237-1
Package Information
Back Pain And Sciatica (aconitum napellus, arnica montana, belladonna, cimicifuga racemosa, euphorbium officinarum, gelsemium sempervirens, gnaphalium polycephalum, hypericum perforatum, magnesia phosphorica, phytolacca decandra, ranunculus bulbosus, rhus tox) sprays is adults and children over 12: Spray twice under the tongue three times per day. This formulation utilizes a spray delivery system. Marketed by Liddell Laboratories, Inc., this product is identified by NDC 50845-0237.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS WHOLE 200 [hp_C]/mL
- ARNICA MONTANA WHOLE 200 [hp_C]/mL
- ATROPA BELLADONNA 6 [hp_X]/mL
- BLACK COHOSH 6 [hp_X]/mL
- EUPHORBIA RESINIFERA RESIN 6 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT 6 [hp_X]/mL
- HYPERICUM PERFORATUM WHOLE 200 [hp_C]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 10 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL
- PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE 30 [hp_X]/mL
- RANUNCULUS BULBOSUS WHOLE 30 [hp_C]/mL
- TOXICODENDRON PUBESCENS LEAF 200 [hp_C]/mL
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 50845 - Liddell Laboratories, Inc.
- 50845-0237 - Back Pain And Sciatica
- 50845-0237-1 - 30 mL in 1 BOTTLE, SPRAY
- 50845-0237 - Back Pain And Sciatica
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50845-0237-1 identifies a specific commercial package of 30 ml in 1 bottle, spray of Back Pain And Sciatica, a human over the counter drug labeled by Liddell Laboratories, Inc.. This spray is formulated for oral use and contains aconitum napellus whole; arnica montana whole; atropa belladonna; black cohosh; euphorbia resinifera resin; gelsemium sempervirens root; hypericum perforatum whole; magnesium phosphate, dibasic trihydrate; phytolacca americana root; pseudognaphalium obtusifolium whole; ranunculus bulbosus whole; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Liddell Laboratories, Inc. on January 30, 2019. The current certification is valid through December 31, 2026.
How is this Liddell Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50845023701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.